Tempus AI против Illumina: какие акции в сфере онкологии стоит купить сейчас?

Компании TEM и ILMN борются за лидерство в области прецизионной онкологии, однако более высокие показатели роста акций, оценка и прогнозы прибыли делают ILMN более привлекательным выбором на данный момент.

Precision oncology, or precise medicine, is an innovative approach in cancer treatment aimed at tailoring therapies to the individual characteristics of each patient. ILMN, or Illumina Inc., is known for its advances in genomic sequencing which is a cornerstone in precision medicine. Meanwhile, Thermo Fisher Scientific (TEM is a common ticker symbol that could refer to this company) also has a significant presence in this space, but ILMN's leadership in sequencing technology gives it a strong competitive edge.